Lin X, Li Y, Wang S, Zhang Y, Chen X, Wei M, Zhu H, Wu A, Yang Z, Wang X. Diagnostic value of [68Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [18F]F-FDG PET/CT. Front Oncol. 2023;12:1087792. https://doi.org/10.3389/fonc.2022.1087792.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wegen S, Roth KS, Weindler J, Claus K, Linde P, Trommer M, Akuamoa-Boateng D, Van Heek L, Baues C, Schömig-Markiefka B, Schomäcker K, Fischer T, Drzezga A, Kobe C, Köhler C, Marnitz S. First clinical experience With [68Ga]Ga-FAPI-46-PET/CT versus [18F]F-FDG PET/CT for nodal staging in cervical cancer. Clin Nucl Med. 2023;48:150–5. https://doi.org/10.1097/RLU.0000000000004505.

Article  PubMed  Google Scholar 

Mona CE, Benz MR, Hikmat F, Grogan TR, Lueckerath K, Razmaria A, Riahi R, Slavik R, Girgis MD, Carlucci G, Kelly KA, French SW, Czernin J, Dawson DW, Calais J. Correlation of 68Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study. J Nucl Med. 2022;63:1021–6. https://doi.org/10.2967/jnumed.121.262426.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ballal S, Yadav MP, Moon ES, Kramer VS, Roesch F, Kumari S, Tripathi M, ArunRaj ST, Sarswat S, Bal C. Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers. Eur J Nucl Med Mol Imaging. 2021;48:1915–31. https://doi.org/10.1007/s00259-020-05132-y.

Article  CAS  PubMed  Google Scholar 

Ferdinandus J, Kessler L, Hirmas N, Trajkovic-Arsic M, Hamacher R, Umutlu L, Nader M, Zarrad F, Weber M, Fendler WP. Equivalent tumor detection for early and late FAPI-46 PET acquisition. Eur J Nucl Med Mol Imaging. 2021;48:3221–7. https://doi.org/10.1007/s00259-021-05266-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, Rathke H, Winter E, Lindner T, Syed M, Bhatti IA, Herfarth K, Choyke PL, Jaeger D, Haberkorn U, Debus J, Giesel FL. The role of 68Ga-FAPI PET/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience. J Nucl Med. 2020;61:1331–6. https://doi.org/10.2967/jnumed.119.237016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39:783–803. https://doi.org/10.1007/s10555-020-09909-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kömek H, Can C, Kaplan İ, Gündoğan C, Kepenek F, Karaoglan H, Demirkıran A, Ebinç S, Güzel Y, Gündeş E. Comparison of [68 Ga]Ga-DOTA-FAPI-04 PET/CT and [18F]FDG PET/CT in colorectal cancer. Eur J Nucl Med Mol Imaging. 2022;49:3898–909. https://doi.org/10.1007/s00259-022-05839-0.

Article  CAS  PubMed  Google Scholar 

Kamali Zonouzi S, Pezeshki PS, Razi S, Rezaei N. Cancer-associated fibroblasts in colorectal cancer. Clin Transl Oncol. 2022;24:757–69. https://doi.org/10.1007/s12094-021-02734-2.

Article  CAS  PubMed  Google Scholar 

Hirmas N, Hamacher R, Sraieb M, Kessler L, Pabst KM, Barbato F, Lanzafame H, Kasper S, Nader M, Kesch C, Von Tresckow B, Hautzel H, Aigner C, Glas M, Stuschke M, Kümmel S, Harter P, Lugnier C, Uhl W, Hadaschik B, Grünwald V, Siveke JT, Herrmann K, Fendler WP. Diagnostic accuracy of 68Ga-FAPI versus18F-FDG PET in patients with various malignancies. J Nucl Med. 2024;65:372–8. https://doi.org/10.2967/jnumed.123.266652.

Article  CAS  PubMed  Google Scholar 

Wu G, Wang D, Zhang W, Jia Z, Li J, Zhang L. Head-to-head comparison of [68Ga]Ga-FAPI PET and [18F]FDG PET in the detection of bone and lymph node metastasis in various cancers: a systematic review and meta-analysis. Eur J Radiol. 2024;171: 111302. https://doi.org/10.1016/j.ejrad.2024.111302.

Article  PubMed  Google Scholar 

Liu S, Feng Z, Xu X, Ge H, Ju X, Wu X, Song S. Head-to-head comparison of [18F]-FDG and [68 Ga]-DOTA-FAPI-04 PET/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer. Eur J Nucl Med Mol Imaging. 2023;50:1521–31. https://doi.org/10.1007/s00259-022-06096-x.

Article  CAS  PubMed  Google Scholar